U.S. Healthcare Services Stock News

Shareholders of Bath & Body Works, Inc. ( NYSE:BBWI ) will be pleased this week, given that the stock price is up 18...

It looks like Agnico Eagle Mines Limited ( NYSE:AEM ) is about to go ex-dividend in the next two days. The ex-dividend...

Tyson Foods, Inc. ( NYSE:TSN ) is about to trade ex-dividend in the next two days. The ex-dividend date is one business...

BorgWarner Inc. ( NYSE:BWA ) is about to trade ex-dividend in the next two days. The ex-dividend date is one business...

Q1 2026 earnings snapshot sets the stage for Autohome (NYSE:ATHM) Autohome (NYSE:ATHM) opened 2026 with Q1 revenue of C¥1,048.4 million and basic EPS of C¥0.38, alongside net income of C¥44.3 million, putting fresh numbers behind a stock currently trading at $17.30. Over the last few quarters, revenue has moved from C¥1,783.4 million in Q4 2024 to C¥1,453.8 million in Q1 2025 and then to C¥1,048.4 million in Q1 2026, while quarterly basic EPS has shifted from C¥2.51 to C¥2.86 and then to...

Wondering if Sociedad Química y Minera de Chile at around US$84.05 is still offering value after a strong run, or if you are arriving late to the story. The stock has returned 6.0% over the past week, is down 6.0% over the past month, but is up 20.5% year to date and 169.1% over the last year, which can change how the market is thinking about its risk and reward profile. Recent coverage has focused on Sociedad Química y Minera de Chile as a key player in materials and lithium related themes,...

Recent price performance and business profile Kemper (KMPR) has been under pressure recently, with the stock down 3% over the past day and 14% over the past week. This has drawn attention to how its insurance business is currently positioned. The company offers specialty auto and life insurance products across the United States through two main segments: Specialty Property & Casualty Insurance and Life Insurance. Total revenue was reported at US$4.7b. See our latest analysis for...

ATI (ATI) heads into its May 28 Bernstein Strategic Decisions Conference appearance with investors already focused on its aerospace and defense tilt, consistent earnings outperformance, and segment reshaping around higher margin materials and components. See our latest analysis for ATI. The stock’s recent run to US$170.53, with a 7 day share price return of 6.3% and a year to date share price return of 43.1%, sits alongside a very large 5 year total shareholder return. This points to momentum...

Agilent Technologies (A) has just reported Q2 2026 results with revenue of US$1,835 million and basic EPS of US$1.20, alongside trailing twelve month revenue of US$7.2 billion and EPS of US$5.00 that sit against a one year earnings growth figure of 21.3%. Over recent quarters, revenue has ranged between US$1,668 million and US$1,861 million while quarterly EPS has moved between roughly US$0.75 and US$1.53, with net profit margin across the last year at 19.6% compared to 17.6% a year earlier...

AI momentum and federal cloud access put Cellebrite DI (NasdaqGS:CLBT) in focus Fresh headlines around broader adoption of Cellebrite DI (NasdaqGS:CLBT) AI and cloud-based investigation tools, plus FedRAMP authorization for its cloud platform, have put the stock back onto investor watchlists. Project Genesis, the company’s new AI tool aimed at cutting investigation times, is seeing early customer interest, and recent updates highlight growth in annual recurring revenue along with a thicker...

If you are trying to figure out whether GE Vernova is attractively priced or already fully valued, the recent share performance gives you a lot to think about. The stock recently closed at US$996.00, with returns of 46.6% year to date and 111.9% over the last year, even though it is down 4.6% over the past week and 8.5% over the past month. Recent coverage has focused on GE Vernova as a standalone listed business following its separation from General Electric. Investors are watching how the...

At its May 20, 2026 annual meeting, Five9 shareholders approved amendments to the company’s charter to declassify the Board of Directors and eliminate supermajority voting requirements, meaning all directors will now stand for election more frequently under standard voting thresholds. This shift materially strengthens shareholder rights and board accountability, potentially making Five9 more responsive to investor input on governance, capital allocation, and long-term corporate...

Momentus (MNTS) has drawn fresh attention after entering securities purchase agreements with existing institutional investors for a private placement of 2,942,000 shares. The transaction is expected to raise about US$25,000,000 in gross proceeds. See our latest analysis for Momentus. The private placement and recent shelf registrations have arrived after a sharp swing in sentiment, with the 30 day share price return of 278.91% and year to date share price return of 237.98% contrasting with a...

Investors may wish to note that the Chief Revenue Officer of TechTarget, Inc. , Steven Niemiec, recently netted US$95k...

Wondering if Forgent Power Solutions at around US$47.56 is offering value or stretching expectations? This article walks through what the current price might be telling you. The stock has eased about 2% over the past week, but is still up 28.9% over the past month and 64.0% year to date, which can change how you think about both upside and risk. Recent coverage has focused on Forgent Power Solutions as investors look more closely at power and grid related companies, with attention on how its...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Recent performance context for Federal Agricultural Mortgage (AGM) Federal Agricultural Mortgage (AGM) has drawn fresh attention after a period of mixed share performance, with modest gains in the past week and month, alongside a decline over the past year and stronger multi‑year total returns. See our latest analysis for Federal Agricultural Mortgage. With the share price at US$179.50 and a 90 day share price return of 13.85%, but a 1 year total shareholder return that is slightly down,...

Why National Beverage stock is drawing attention National Beverage (FIZZ) is back on investors’ radar after a recent share price move, with returns over the past month and past 3 months prompting closer scrutiny of its fundamentals and valuation. See our latest analysis for National Beverage. At a recent share price of US$37.24, the stock has a 1 month share price return of 7.91% and a year to date share price return of 17.62%, yet the 1 year total shareholder return is down 16.95%. This...

In late May, a Blue Origin New Glenn rocket exploded during testing, raising questions about future launch availability for AST SpaceMobile. The incident follows the loss of a BlueBird satellite in April due to a separate launch failure that affected the company’s deployment schedule. AST SpaceMobile has already shifted its next BlueBird batch to a planned mid June Falcon 9 launch with SpaceX from Cape Canaveral. The stock, NasdaqGS:ASTS, last closed at $133.09, with very large 1 year...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Garrett...

Wondering if Vulcan Materials at a recent US$276.75 close is priced appropriately for its future or offering limited value? This article walks through what the numbers actually say about the stock. Recent returns have been mixed, with the stock up 5.6% over the past week, down 5.0% over the past month, down 5.4% year to date, and up 5.1% over the past year, which can signal changing views on both opportunity and risk. Recent news flow around Vulcan Materials has centered on ongoing interest...

The United States market has shown robust performance recently, climbing 1.8% in the last seven days and rising 28% over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, identifying small-cap stocks that are potentially undervalued and experiencing insider action can present unique opportunities for investors seeking to capitalize on growth prospects within emerging companies.

EyePoint Pharmaceuticals recently presented at the Stifel 2026 Virtual Ophthalmology Forum and reiterated that top-line Phase 3 data for its wet age-related macular degeneration (AMD) therapy DURAVYU are expected to begin reading out in August, with a second pivotal trial to follow about two months later. Management highlighted 2026 as potentially transformative, emphasizing ambitions for DURAVYU to match a leading therapy on vision outcomes while maintaining safety and reducing treatment...

Lantheus Holdings (NasdaqGM:LNTH) plans to present new clinical data for LNTH-2403, an LRRC15-targeted radiopharmaceutical, at the 2026 ASCO Annual Meeting. The company will also share real-world data on piflufolastat F 18 imaging use in early-stage prostate cancer at the same conference. These updates provide fresh detail on both Lantheus's osteosarcoma pipeline and the adoption of its approved prostate cancer imaging agent. Lantheus focuses on radiopharmaceuticals and imaging agents used...